Clinical Trials Logo

Allergy to Cats clinical trials

View clinical trials related to Allergy to Cats.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05455749 Completed - Clinical trials for Allergic Rhinoconjunctivitis

Effect of holoBLG on Cat Allergic Patients

Start date: October 4, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the antigen-unspecific effect of a 3 months supplementation with a food for special medical purposes (FSMP) in form of a lozenge containing beta-lactoglobulin (BLG), iron, retinoic acid, zinc and polyphenols (holo-BLG) in patients with allergic rhinoconjunctivitis caused by cat (hair/dander) and the associated symptoms (symptom type and severity) during exposure to cat allergen in an Allergen Exposure Chamber (AEC).

NCT ID: NCT04678063 Completed - Allergy Clinical Trials

Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma

Start date: April 10, 2017
Phase: N/A
Study type: Interventional

This is a randomized, double blind, cross-over study designed to determine the concentration of airborne cat allergen inducing bronchial response in asthmatic subjects allergic to cat, during allergen exposures in the Alyatec environmental exposure chamber (EEC). The study was also designed to validate the specificity of the asthmatic reaction induced by exposure to airborne cat allergen in Alyatec EEC.

NCT ID: NCT00620880 Completed - Allergy to Cats Clinical Trials

IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Start date: September 2005
Phase: N/A
Study type: Observational

Primary objective of the trial: To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone